Physiopathology of SARS-CoV-2-infection-associated thrombosis.
作者信息
Casella Ivan Benaduce
机构信息
Universidade de São Paulo - USP, Faculdade de Medicina, Hospital das Clínicas, São Paulo, SP, Brasil.
出版信息
J Vasc Bras. 2020 Sep 21;19:e20200128. doi: 10.1590/1677-5449.200128.
Abstract
摘要
相似文献
1
Physiopathology of SARS-CoV-2-infection-associated thrombosis.严重急性呼吸综合征冠状病毒2感染相关血栓形成的病理生理学
J Vasc Bras. 2020 Sep 21;19:e20200128. doi: 10.1590/1677-5449.200128.
2
Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches.感染、动脉血栓形成和 COVID-19 疾病以外的血栓栓塞：病理生理学和研究中的相似之处。
Aging Clin Exp Res. 2021 Feb;33(2):273-278. doi: 10.1007/s40520-020-01775-x. Epub 2021 Jan 15.
3
Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis.维生素缺乏作为 SARS-CoV-2 感染的风险因素：与易感性和预后的相关性。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9721-9738. doi: 10.26355/eurrev_202009_23064.
4
SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study.SARS-CoV-2 暴发性心肌炎：尸检和组织病理学案例研究。
Int J Legal Med. 2021 Mar;135(2):577-581. doi: 10.1007/s00414-020-02500-z. Epub 2021 Jan 3.
5
COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.COVID-19：潜在的脂肪因子风暴与血管紧张素 1-7 伞状系统。
Front Immunol. 2020 Jul 21;11:1714. doi: 10.3389/fimmu.2020.01714. eCollection 2020.
6
Isolated posterior tibial artery thrombosis after non-severe SARS-CoV-2 infection.非重症新型冠状病毒肺炎感染后孤立性胫后动脉血栓形成
Rev Soc Bras Med Trop. 2021 Jun 2;54:e02052021. doi: 10.1590/0037-8682-0205-2021. eCollection 2021.
7
Spirometry during the SARS-CoV-2 pandemic. Guidelines and practical advice from the expert panel of Respiratory Physiopathology Assembly of Polish Respiratory Society.SARS-CoV-2 大流行期间的肺量测定。波兰呼吸学会呼吸病理生理学分会专家组的指南和实用建议。
Adv Respir Med. 2020;88(6):640-650. doi: 10.5603/ARM.a2020.0186.
8
[Treatment options for enormous carotid thrombus as a complication of SARS-CoV-2 infection].[严重急性呼吸综合征冠状病毒2感染并发症巨大颈动脉血栓的治疗选择]
Ideggyogy Sz. 2021 Mar 30;74(3-4):129-134. doi: 10.18071/isz.74.0129.
9
Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).2019冠状病毒病（COVID-19）患者的血栓形成与抗磷脂抗体
Int J Lab Hematol. 2020 Dec;42(6):e280-e282. doi: 10.1111/ijlh.13320. Epub 2020 Aug 26.
10
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.新型冠状病毒病（COVID-19）所致急性呼吸窘迫综合征（ARDS）：实用综合文献复习。
Expert Rev Respir Med. 2021 Feb;15(2):183-195. doi: 10.1080/17476348.2020.1820329. Epub 2020 Oct 18.
引用本文的文献
1
Thromboinflammation vs. immunothrombosis: strategies for overcoming anticoagulant resistance in COVID-19 and other hyperinflammatory diseases. Is ROTEM helpful or not?血栓炎症与免疫血栓形成：克服COVID-19和其他高炎症性疾病中抗凝抵抗的策略。旋转血栓弹力图（ROTEM）是否有用？
Front Immunol. 2025 Jun 19;16:1599639. doi: 10.3389/fimmu.2025.1599639. eCollection 2025.
2
Immunothrombosis and its underlying biological mechanisms.免疫血栓形成及其潜在生物学机制。
Hematol Transfus Cell Ther. 2024 Jan-Mar;46(1):49-57. doi: 10.1016/j.htct.2023.05.008. Epub 2023 Jul 1.
3
SARS-CoV-2 infection-associated thoraco-abdomino-iliac thrombosis in a patient without cardiac and systemic co-morbidity.SARS-CoV-2 感染相关的胸腹部髂血栓形成，发生于无心脏和系统性合并症的患者。
Cardiovasc J Afr. 2023 May-Jun;34(2):114-116. doi: 10.5830/CVJA-2022-025.
4
Effect of Previous Anticoagulant Treatment on Risk of COVID-19.既往抗凝治疗对 COVID-19 风险的影响。
Drug Saf. 2023 Mar;46(3):273-281. doi: 10.1007/s40264-022-01266-0. Epub 2022 Dec 23.
5
What cellular mechanisms are related to thromboembolic events in patients with COVID-19?新型冠状病毒肺炎（COVID-19）患者血栓栓塞事件涉及哪些细胞机制？
J Vasc Bras. 2021 Aug 2;20:e20210020. doi: 10.1590/1677-5449.210020. eCollection 2021.
本文引用的文献
1
Neutrophil extracellular traps and thrombosis in COVID-19.新冠病毒肺炎中的中性粒细胞胞外诱捕网与血栓形成
J Thromb Thrombolysis. 2021 Feb;51(2):446-453. doi: 10.1007/s11239-020-02324-z. Epub 2020 Nov 5.
2
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?2019冠状病毒病的血栓预防：抗Xa因子——缺失的因素？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):455-457. doi: 10.1164/rccm.202005-1654LE.
3
Heparin resistance in COVID-19 patients in the intensive care unit.COVID-19 患者在重症监护病房中肝素耐药。
J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0.
4
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
5
Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.严重 COVID-19 感染中纤维蛋白溶解关闭与血栓栓塞事件的相关性。
J Am Coll Surg. 2020 Aug;231(2):193-203.e1. doi: 10.1016/j.jamcollsurg.2020.05.007. Epub 2020 May 15.
6
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome.中国武汉 COVID-19 住院患者的深静脉血栓形成：患病率、危险因素和结局。
Circulation. 2020 Jul 14;142(2):114-128. doi: 10.1161/CIRCULATIONAHA.120.046702. Epub 2020 May 18.
7
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.确认 COVID-19 重症 ICU 患者的血栓并发症累积发生率较高：更新分析。
Thromb Res. 2020 Jul;191:148-150. doi: 10.1016/j.thromres.2020.04.041. Epub 2020 Apr 30.
8
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
9
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
10
ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?ACE2：理解 COVID-19 严重和危急情况病理生理学的关键分子：是魔鬼还是天使？
Viruses. 2020 Apr 28;12(5):491. doi: 10.3390/v12050491.
Zotero 插件